Committed to developing
novel vaccines
We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.
Join a dynamic team dedicated to making a difference
Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.
Recent News
DYNAVAX®, HEPLISAV-B®, and CpG 1018® are registered trademarks of Dynavax Technologies Corporation.